Thursday, 21 March 2019

Neuberg Diagnostics partners with Premaitha Health

02 July 2018 | News

The IONA test developed by Premaitha is accurate in detecting risks that an unborn child carries for genetic disorders.

Image credit-

Image credit-

Neuberg Diagnostics has partnered with UK’s Premaitha Health for transfer of DNA analysis technology for non-invasive prenatal testing to detect genetic conditions in unborn babies.

According to Neuberg, the IONA test (developed by Premaitha) is accurate in detecting risks that an unborn child carries for genetic disorders like Down’s syndrome, Edward’s syndrome and Patau’s syndrome.

The test developed by the UK-based molecular diagnostics company uses next generation sequencing technology to estimate the risk of a foetus having genetic disorders.

The test is conducted by analysing foetal DNA collected from a sample of maternal blood and has a higher detection rate than current available tests. Testing of the high-tech technology will be carried out at Neuberg’s laboratory in Ahmedabad.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Can collaboration between startups and big life sciences companies offer a disruptive breakthrough?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls